Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thujone is a bicyclic monoterpene ketone (C10H16O) present in several essential oils—most famously in Artemisia absinthium (wormwood), sage, and Thuja species. Thujone exists naturally in two main diastereomeric forms—α-thujone and β-thujone—with additional enantiomers and isomers possible. Thujone acts as a reversible inhibitor at the GABA-A receptor, which can cause convulsant and neurotoxic effects at higher exposures by interfering with neuronal inhibition. It is not itself a drug target, but a bioactive phytochemical with noted toxicological and pharmacological properties. Thujone's best-known historical association is as a constituent of absinthe and the cause of that beverage’s reputed neurotoxicity at high doses, though these effects are primarily due to thujone's antagonism of GABAergic neurotransmission. Important clarification: Thujone is a ligand (natural or synthetic molecule that binds to a biological target), but not a therapeutic target itself. The GABA-A receptor would be the therapeutically relevant target in this context. Querying "Thujone" as a target is therefore incorrect as defined by biomedical target conventions. Summary for structured extraction: Thujone is a phytochemical monoterpene, not a molecular target. Not a receptor, enzyme, or transporter. Biological activity: Inhibits GABA-A receptor function as a non-competitive antagonist, which can cause CNS excitation and convulsions at high doses. Not clinically used as a drug. Associated safety risks: neurotoxicity, convulsant effect, potential toxicity via ingestion especially in high-dose or concentrated extracts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thujone.